Upper and lower gastrointestinal symptoms in HIV-infected adults in a clinical cohort in Midwestern Brazil: incidence and associated factors

A. Santos, É. A. Silveira
{"title":"Upper and lower gastrointestinal symptoms in HIV-infected adults in a clinical cohort in Midwestern Brazil: incidence and associated factors","authors":"A. Santos, É. A. Silveira","doi":"10.15761/crt.1000281","DOIUrl":null,"url":null,"abstract":"Aim : The present study aimed to investigate the incidence of both upper and lower gastrointestinal symptoms and associated factors in HIV-infected adults with or without antiretroviral therapy (ART). Methodology : This study is part of a clinical cohort conducted with adult HIV-infected adults in Midwestern Brazil on outpatient care. Outcome variables were the presence of upper (nausea/vomiting, dyspepsia, and heartburn) and lower (diarrhea, constipation, and flatulence) gastrointestinal symptoms incident on the week before data collection. Explanatory variables were sex, tobacco use, nutritional status, waist circumference (WC), duration of ART, protease inhibitors (PI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) use, and CD4+ T lymphocyte count. The estimate of the effect was analyzed by the incidence ratio (IR) and 95% confidence interval (CI). Statistical significance level was set at p<0.05. Results : Of 290 study participants, 69.0% were on ART. The most incident gastrointestinal symptom was heartburn (49.3%), followed by flatulence (43.4%), dyspepsia (24.5%), nausea/vomiting (22.8), diarrhea (18.3%), and constipation (16.2%). No difference was observed in the incidence of gastrointestinal symptoms in participants with or without ART. The associated factors with upper and/or lower gastrointestinal symptoms were female sex, excess of body weight, abdominal obesity, less than one year of ART use, tobacco exposure, and CD4+ T lymphocyte count. Conclusion : A high incidence of several gastrointestinal symptoms was found in HIV-infected adults, associated with both modifiable and non-modifiable risk factors. These findings contribute to gastrointestinal symptoms management in clinical practice for people living with HIV/AIDS, mainly those in risk categories, as gastrointestinal symptoms could result in adverse outcomes for this population.","PeriodicalId":90808,"journal":{"name":"Clinical research and trials","volume":"58 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical research and trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/crt.1000281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Aim : The present study aimed to investigate the incidence of both upper and lower gastrointestinal symptoms and associated factors in HIV-infected adults with or without antiretroviral therapy (ART). Methodology : This study is part of a clinical cohort conducted with adult HIV-infected adults in Midwestern Brazil on outpatient care. Outcome variables were the presence of upper (nausea/vomiting, dyspepsia, and heartburn) and lower (diarrhea, constipation, and flatulence) gastrointestinal symptoms incident on the week before data collection. Explanatory variables were sex, tobacco use, nutritional status, waist circumference (WC), duration of ART, protease inhibitors (PI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) use, and CD4+ T lymphocyte count. The estimate of the effect was analyzed by the incidence ratio (IR) and 95% confidence interval (CI). Statistical significance level was set at p<0.05. Results : Of 290 study participants, 69.0% were on ART. The most incident gastrointestinal symptom was heartburn (49.3%), followed by flatulence (43.4%), dyspepsia (24.5%), nausea/vomiting (22.8), diarrhea (18.3%), and constipation (16.2%). No difference was observed in the incidence of gastrointestinal symptoms in participants with or without ART. The associated factors with upper and/or lower gastrointestinal symptoms were female sex, excess of body weight, abdominal obesity, less than one year of ART use, tobacco exposure, and CD4+ T lymphocyte count. Conclusion : A high incidence of several gastrointestinal symptoms was found in HIV-infected adults, associated with both modifiable and non-modifiable risk factors. These findings contribute to gastrointestinal symptoms management in clinical practice for people living with HIV/AIDS, mainly those in risk categories, as gastrointestinal symptoms could result in adverse outcomes for this population.
巴西中西部一个临床队列中hiv感染成人的上消化道和下消化道症状:发病率和相关因素
目的:本研究旨在调查接受或未接受抗逆转录病毒治疗(ART)的hiv感染成人中上消化道和下消化道症状的发生率及其相关因素。方法:本研究是巴西中西部门诊治疗的成年hiv感染者临床队列研究的一部分。结果变量为收集数据前一周出现的上消化道(恶心/呕吐、消化不良和胃灼热)和下消化道(腹泻、便秘和胀气)症状。解释变量为性别、烟草使用、营养状况、腰围(WC)、ART持续时间、蛋白酶抑制剂(PI)和非核苷类逆转录酶抑制剂(NNRTI)的使用以及CD4+ T淋巴细胞计数。采用发生率比(IR)和95%置信区间(CI)对效果进行估计分析。差异有统计学意义,p<0.05。结果:在290名研究参与者中,69.0%的人接受了ART治疗。最常见的胃肠道症状是胃灼热(49.3%),其次是肠胃胀气(43.4%)、消化不良(24.5%)、恶心/呕吐(22.8%)、腹泻(18.3%)和便秘(16.2%)。在接受或不接受抗逆转录病毒治疗的参与者中,胃肠道症状的发生率没有观察到差异。上消化道和/或下消化道症状的相关因素为女性、体重过重、腹部肥胖、使用抗逆转录病毒治疗不到一年、吸烟和CD4+ T淋巴细胞计数。结论:艾滋病毒感染成人中几种胃肠道症状发生率高,与可改变和不可改变的危险因素相关。这些发现有助于在临床实践中对艾滋病毒/艾滋病感染者(主要是高危人群)进行胃肠道症状管理,因为胃肠道症状可能导致该人群的不良后果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信